The TRANSLATE-ACS Study: Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome.

Trial Profile

The TRANSLATE-ACS Study: Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Aug 2017

At a glance

  • Drugs Prasugrel (Primary) ; Anticoagulants; Aspirin; Clopidogrel; Platelet ADP receptor antagonists
  • Indications Acute coronary syndromes; Cardiovascular disorders; Coronary artery disease; Embolism and thrombosis; Myocardial infarction
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms TRANSLATE-ACS
  • Sponsors Eli Lilly
  • Most Recent Events

    • 01 May 2017 Results (n=671) published in the American Heart Journal.
    • 07 Feb 2017 Results assessing race and sex differences in post-myocardial infarction angina frequency and risk of 1-year unplanned rehospitalization, published in the Circulation
    • 01 Jan 2017 Results published in the American Heart Journal
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top